Clinical trial
Pilot Pharmacokinetic Study In Patients With Inadequate Response To Deferasirox (Exjade)
NCT00749515 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Pharmacokinetic Study In Patients With Inadequate Response To Deferasirox (Exjade)
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- November 30, 2008
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease, thalassemia major, transfusion-dependent hemachromatosis